JFG
RGNX icon

Jefferies Financial Group’s Regenxbio RGNX Stock Holding History

Jefferies Financial Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-400,000
Closed -$5.8M – 1805
2024
Q3 		$5.8M Buy
+400,000
New +$4.88M 0.04% 285

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Financial Group's RGNX Position: Q1 2026 in Review

Jefferies Financial Group opened a new position in Regenxbio (RGNX) in Q1 2026: 95,400 shares worth $799K. The stake represents 0.01% of the portfolio and ranks #1010 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in RGNX as recently as Q1 2023.

Jefferies Financial Group first reported a position in RGNX in Q1 2023 and has held it in 2 quarters since. The position peaked at $1.27M in Q1 2023. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Jefferies Financial Group held 95,400 shares of Regenxbio worth $799K as of Q1 2026.
  • Regenxbio was a new Jefferies Financial Group position in Q1 2026.
  • Regenxbio made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1010 holding.
  • Jefferies Financial Group first reported a position in Regenxbio in Q1 2023 and has held it in 2 quarters since.
  • Jefferies Financial Group's Regenxbio position peaked at $1.27M in Q1 2023.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.